A prospective, single center, double blind, placebo controlled study of adipocytokines, adipose tissue gene expression and hepatic insulin clearance in the therapeutic response to vildagliptin in man.
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2012
At a glance
- Drugs Metformin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 27 Jul 2011 New trial record